Abstract
High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin–producing E. coli strains recovered from patients in Michigan during 2010–2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistance could contribute to more severe disease outcomes.
Cite
CITATION STYLE
Mukherjee, S., Mosci, R. E., Anderson, C. M., Snyder, B. A., Collins, J., Rudrik, J. T., & Manning, S. D. (2017, September 1). Antimicrobial drug–resistant Shiga toxin–producing Escherichia coli infections, Michigan, USA. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2309.170523
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
